Introduction: COVID-19 has been a challenge for healthcare, mainly in elderly patients
in Nursing Homes (NHs) and Long-Term Care Facilities (LTCFs). We present a pioneering novel
experience in addressing healthcare of elderly patients with COVID-19 in these facilities by a reconversion
of a NH in a medicalized NH.
Methods: All patients admitted to the center were included, recording clinical and epidemiological
variables. We conducted a descriptive analysis and a multivariate analysis to identify variables
linked to mortality and persistence of positive PCR test.
Results: 84 patients were included (40% men), women presented more symptomatology. We found
a positive correlation between the duration of symptoms and the days required to obtain a negative
PCR test (r=0.512, P<0.001). We also found an independent and significant association between asthenia
(OR=2.58; IC95% 1.22-5.46) and mutism (OR=5.21; IC95% 1.58-17.15) and a longer time
to achieve a negative PCR test. All patients, except contraindication, were treated with hydroxychloroquine
and azithromycin, which was the recommended treatment during the period of the
study. The early start of corticoid treatment (within the first 72 hours since the start of symptoms)
was linked to a lower mortality in patients with moderate-severe symptoms. Mortality was lower
than expected (which was higher than 20% in that period and group of age), reaching 14%, the
main factors linked to mortality were the presence of mutism (OR=19; IC95% 3.4-108; P=0.001)
and dyspnea (OR=12; IC95% 1.3-111; P=0.029).
Conclusions: An alternative system was presented for the care of these patients through the reconversion
of a basic NH in a medicalized one, which showed a significant reduction in the expected